Advanced gut microbiome characterization to understand drug–microbiome interactions and optimize treatment outcomes.
Our microbiome analysis service provides a detailed characterization of the gut microbiome and its impact on drug absorption and metabolism. By combining 16S rRNA sequencing with metabolomic profiling, we reveal how an individual's unique microbial ecosystem affects pharmaceutical outcomes. This information helps clinicians anticipate drug–microbiome interactions and optimize therapeutic strategies.
Reach out to discuss how this service can be integrated into your clinical workflow.
Contact Us